Search Results - "Nagai, Hidenari"

Comparison of strain elastography and shear wave elastography in diagnosis of fibrosis in nonalcoholic fatty liver disease by Ogino, Yu, Wakui, Noritaka, Nagai, Hidenari, Matsuda, Takahisa

“…Purpose To reveal the ability of S-Map strain elastography to diagnose fibrosis in nonalcoholic fatty liver disease (NAFLD) and to compare its diagnostic…”
Get full text

Tivantinib Decreases Hepatocyte Growth Factor-Induced BCRP Expression in Hepatocellular Carcinoma HepG2 Cells by Kobayashi, Kojiro, Higai, Koji, Mukozu, Takanori, Matsui, Daigo, Amanuma, Makoto, Yoshimine, Naoyuki, Ogino, Yu, Matsui, Teppei, Wakui, Noritaka, Shinohara, Mie, Momiyama, Koichi, Daido, Yasuko, Nagai, Hidenari, Igarashi, Yoshinori

“…Tivantinib, a mesenchymal–epithelial transition factor (cMET) inhibitor, is a molecular targeting drug that kills hepatocellular carcinoma (HCC) cells…”
Get full text

Fibroblast growth factor 18 stimulates the proliferation of hepatic stellate cells, thereby inducing liver fibrosis by Tsuchiya, Yuichi, Seki, Takao, Kobayashi, Kenta, Komazawa-Sakon, Sachiko, Shichino, Shigeyuki, Nishina, Takashi, Fukuhara, Kyoko, Ikejima, Kenichi, Nagai, Hidenari, Igarashi, Yoshinori, Ueha, Satoshi, Oikawa, Akira, Tsurusaki, Shinya, Yamazaki, Soh, Nishiyama, Chiharu, Mikami, Tetuo, Yagita, Hideo, Okumura, Ko, Kido, Taketomo, Miyajima, Atsushi, Matsushima, Kouji, Imasaka, Mai, Araki, Kimi, Imamura, Toru, Ohmuraya, Masaki, Tanaka, Minoru, Nakano, Hiroyasu

“…Liver fibrosis results from chronic liver injury triggered by factors such as viral infection, excess alcohol intake, and lipid accumulation. However, the…”
Get full text

Hepatitis B Virus-related Membranous Nephropathy with Crescentic Formation in an Inactive Carrier of Positive Hepatitis B Surface Antigen with Undetectable DNA under Anti-viral Treatment by Kounoue, Noriyuki, Oguchi, Hideyo, Mikami, Tetuo, Yamaguchi, Yutaka, Hashiguchi, Akinori, Nagai, Hidenari, Watanabe, Kaori, Furukawa, Satoshi, Hisamatsu, Kana, Sakai, Ken

“…A man who was an inactive hepatitis B virus (HBV) carrier with positive hepatitis B surface antigen (HBs antigen) and undetectable HBV-DNA under anti-viral…”
Get full text

The ultrasound‐guided attenuation parameter is useful in quantification of hepatic steatosis in non‐alcoholic fatty liver disease by Ogino, Yu, Wakui, Noritaka, Nagai, Hidenari, Igarashi, Yoshinori

“…Aim To determine the utility of the ultrasound‐guided attenuation parameter (UGAP) for quantifying hepatic steatosis in non‐alcoholic fatty liver disease…”
Get full text

Hepatocellular carcinoma development in diabetic patients: a nationwide survey in Japan by Tateishi, Ryosuke, Matsumura, Takeshi, Okanoue, Takeshi, Shima, Toshihide, Uchino, Koji, Fujiwara, Naoto, Senokuchi, Takafumi, Kon, Kazuyoshi, Sasako, Takayoshi, Taniai, Makiko, Kawaguchi, Takumi, Inoue, Hiroshi, Watada, Hirotaka, Kubota, Naoto, Shimano, Hitoshi, Kaneko, Shuichi, Hashimoto, Etsuko, Watanabe, Sumio, Shiota, Goshi, Ueki, Kohjiro, Kashiwabara, Kosuke, Matsuyama, Yutaka, Tanaka, Hideo, Kasuga, Masato, Araki, Eiichi, Koike, Kazuhiko

“…Background Although type 2 diabetes mellitus (T2DM) is a known risk factor for hepatocellular carcinoma (HCC) development, the annual incidence in diabetes…”
Get full text

Adaptation of lenvatinib treatment in patients with hepatocellular carcinoma and portal vein tumor thrombosis by Mukozu, Takanori, Nagai, Hidenari, Matsui, Daigo, Mohri, Kunihide, Watanabe, Go, Yoshimine, Naoyuki, Amanuma, Makoto, Kobayashi, Kojiro, Ogino, Yu, Matsukiyo, Yasushi, Matsui, Teppei, Daido, Yasuko, Wakui, Noritaka, Shinohara, Mie, Momiyama, Koichi, Higai, Koji, Igarashi, Yoshinori

“…Purpose The aim of this study was to clarify the adaptation of lenvatinib treatment in patients with hepatocellular carcinoma (HCC) and portal vein tumor…”
Get full text

Whole hepatic lipid volume quantification and color mapping by multi‐slice and multi‐point magnetic resonance imaging by Igarashi, Hiroyuki, Shigiyama, Fumika, Wakui, Noritaka, Nagai, Hidenari, Shibuya, Kazutoshi, Shiraga, Nobuyuki, Hirose, Takahisa, Kumashiro, Naoki

“…Aim Current approaches for hepatic steatosis assess only a small point within the liver and might cause inaccuracy for longitudinal observation. We aimed to…”
Get full text

Host Immunological Effects of Partial Splenic Embolization in Patients with Liver Cirrhosis by Igarashi, Yoshinori, Matsui, Teppei, Nagai, Hidenari, Matsukiyo, Yasushi

“…Purpose. Restoration of the balance between T lymphocyte subsets and between Th1/Th2 cytokines together with improvement of antitumor immunity has been…”
Get full text

Risk factors for lenvatinib‐induced palmar‐plantar erythrodysesthesia syndrome in patients with hepatocellular carcinoma: A retrospective study by Uekusa, Shusuke, Nemoto, Maho, Hanai, Yuki, Nakashin, Misaki, Yanagino, Sachiko, Arita, Yoshiki, Matsumoto, Takahiro, Wakui, Noritaka, Nagai, Hidenari, Higai, Koji, Matsuo, Kazuhiro

“…Aim Lenvatinib mesylate (LEN) is an oral tyrosine kinase inhibitor used to treat various cancers, including hepatocellular carcinoma (HCC). HCC treatment with…”
Get full text

A case of multiple hepatocellular carcinoma experiencing complete responses to sorafenib and atezolizumab–bevacizumab and developing severe, refractory venous congestive cutaneous ulcers on either regimen by Hayashi, Yorihito, Kaneko, Rena, Ogino, Hiroki, Uekusa, Toshimasa, Kitajima, Mayako, Ikehara, Takashi, Nagai, Hidenari, Matsuda, Takahisa

“…A man in his eighties presented with a history of bilateral leg congestive phlebitis, and multiple hepatocellular carcinoma (HCC) treated with sorafenib. When…”
Get full text

Usefulness of partial splenic embolization for left-sided portal hypertension in a patient with a pancreatic neuroendocrine neoplasm: a case report and review of the literature by Matsui, Teppei, Nagai, Hidenari, Amanuma, Makoto, Kobayashi, Kojiro, Ogino, Yu, Mukozu, Takanori, Wakui, Noritaka, Okano, Naoki, Kikuchi, Yoshinori, Matsuda, Takahisa, Igarashi, Yoshinori

“…Left-side portal hypertension (LSPH) is caused by isolated obstruction of the splenic vein and is associated with esophagogastric varices that extend from the…”
Get full text

Effect of Hepatic Inflammation in Chronic Hepatitis C Infection on Fibrosis Assessment by Arrival Time Parametric Imaging by Wakui, Noritaka, Nagai, Hidenari, Matsukiyo, Yasushi, Ogino, Yu, Matsui, Daigo, Mukozu, Takanori, Kogame, Michio, Matsui, Teppei, Daido, Yasuko, Momiyama, Koichi, Maruyama, Kenichi, Kudo, Takahide, Shinohara, Mie, Ikehara, Takashi, Sumino, Yasukiyo, Igarashi, Yoshinori

“…ABSTRACTArrival time parametric imaging (At-PI) in contrast-enhanced ultrasonography is useful for assessing liver fibrosis in chronic hepatitis C (CHC)…”
Get full text

Usefulness of virtual touch tissue quantification for predicting the presence of esophageal varices in patients with liver cirrhosis by Matsui, Teppei, Nagai, Hidenari, Watanabe, Gou, Yoshimine, Naoyuki, Amanuma, Makoto, Kobayashi, Kojiro, Ogino, Yuu, Mukozu, Takanori, Matsukiyo, Yasushi, Daido, Yasuko, Wakui, Noritaka, Nakano, Shigeru, Shinohara, Mie, Momiyama, Koichi, Kudo, Takehide, Maruyama, Kenichi, Igarashi, Yoshinori

“…Background and Aim Measuring the hepatic venous pressure gradient (HVPG) is an established technique to detect increased portal pressure and predict the…”
Get full text

Characteristics of hepatic insulin‐sensitive nonalcoholic fatty liver disease by Shigiyama, Fumika, Kumashiro, Naoki, Furukawa, Yasuhiko, Funayama, Takashi, Takeno, Kageumi, Wakui, Noritaka, Ikehara, Takashi, Nagai, Hidenari, Taka, Hikari, Fujimura, Tsutomu, Uchino, Hiroshi, Tamura, Yoshifumi, Watada, Hirotaka, Nemoto, Tetsuo, Shiraga, Nobuyuki, Sumino, Yasukiyo, Hirose, Takahisa

“…Nonalcoholic fatty liver disease (NAFLD) plays a crucial role in type 2 diabetes and hepatocellular carcinoma. The major underlying pathogenesis is hepatic…”
Get full text

Therapeutic strategy of advanced hepatocellular carcinoma by using combined intra-arterial chemotherapy by Nagai, Hidenari, Sumino, Yasukiyo

“…The majority of primary liver cancer is hepatocellular carcinoma (HCC). HCC has increased in many countries, particularly where hepatitis C virus infection is…”
Get more information

Sorafenib Prevents Escape from Host Immunity in Liver Cirrhosis Patients with Advanced Hepatocellular Carcinoma by Ishii, Koji, Igarashi, Yoshinori, Sumino, Yasukiyo, Shinohara, Mie, Momiyama, Kouichi, Wakui, Noritaka, Kanayama, Masahiro, Kanekawa, Takenori, Matsui, Daigo, Mukozu, Takanori, Nagai, Hidenari, Iida, Kazunari

“…Purpose. It has been reported that Th2 cytokines downregulate antitumor immunity, while activation of type T cells promotes antitumor immunity. The aim of this…”
Get full text

Twenty-four hour intra-arterial infusion of 5-fluorouracil, cisplatin, and leucovorin is more effective than 6-hour infusion for advanced hepatocellular carcinoma by Nagai, Hidenari, Kanayama, Masahiro, Higami, Katsuya, Momiyama, Kouichi, Ikoma, Akiko, Okano, Naoki, Matsumaru, Katsuhiko, Watanabe, Manabu, Ishii, Koji, Sumino, Yasukiyo, Miki, Kazumasa

“…AIM. To evaluate the time dependence of intra-arterial 5-fluorouracil （5-FU） therapy for advanced hepatocellular carcinoma （aHCC）. METHODS： Thirty-seven adult…”
Get full text

Diagnosis of hepatic hemangioma by parametric imaging using sonazoid-enhanced US by Wakui, Noritaka, Takayama, Ryuji, Kamiyama, Naohisa, Takahashi, Masayoshi, Shiozawa, Kazue, Nagai, Hidenari, Watanabe, Manabu, Ishii, Koji, Iida, Kazunari, Igarashi, Yoshinori, Sumino, Yasukiyo

“…Comparison of Parametric Imaging (PI) using Sonazoid-enhanced ultrasonography (US) and microflow imaging (MFI) to determine the possibility of hepatic…”
Get more information

Sorafenib Might Induce Sarcopenia in Patients With Hepatocellular Carcinoma by Inhibiting Carnitine Absorption by Amanuma, Makoto, Nagai, Hidenari, Igarashi, Yoshinori

“…Background/Aim: Tyrosine kinase inhibitors (TKIs) have revolutionized the treatment of cancers. Sorafenib, an oral multi-target TKI, improves the median…”
Get full text